Warehouse Overstock Promotion |  Save 10%  on Premium Lab Supplies |  Shop Now

Menu

This product has been added to the cart.

Recombinant Mouse Interferon γ/IFNG Protein (Human Cells)

SKU: PKSM041064-50

  • $ 21195
  • Save $ 2600


Request a Quote

Recombinant Mouse Interferon γ/IFNG Protein (Human Cells)

 

SKU # PKSM041064
Expression Host HEK293 Cells

 

 

Description

Synonyms IFN-gamma, Ifng, Interferon gamma
Species Mouse
Expression Host HEK293 Cells
Sequence His23-Cys155
Accession P01580
Calculated Molecular Weight 15.5 kDa
Observed Molecular Weight 12-20 kDa
Tag None
Bio-activity Not validated for activity
  

 

Properties

Purity > 95 % as determined by reducing SDS-PAGE.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method.
Storage Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping This product is provided as lyophilized powder which is shipped with ice packs.
Formulation Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution Please refer to the printed manual for detailed information.



Background

Mouse Ifng is a secreted protein which belongs to the type I I (or gamma) interferon family. IFNG is produced by lymphocytes and activated by specific antigens or mitogens. In addition to having antiviral activity, IFNG also has important immunoregulatory functions. It is a potent activator of macrophages and has antiproliferative effects on transformed cells. It can potentiate the antiviral and antitumor effects of the type I interferons. Genetic variation in IFNG is associated with the risk of aplastic anemia (AA) which is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis.